Need professional-grade analysis? Visit stockanalysis.com
$62.74B
243.57
5,597
0.47%
Xizang Haisco Pharmaceutical Group Co Ltd (002653) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY56.02, down 1.46% from the previous close.
Over the past year, 002653 has traded between a low of CNY40.99 and a high of CNY61.47. The stock has gained 22.9% over this period. It is currently 8.9% below its 52-week high.
Xizang Haisco Pharmaceutical Group Co Ltd has a market capitalization of $62.74B, with a price-to-earnings ratio of 243.57 and a dividend yield of 0.47%.
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Side-by-side comparison against top Healthcare peers.